Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Generative A.I. Designs Novel Synthetic Proteins

Human machine interface

Generate:Biomedicines describes its Chroma generative A.I. model in yesterday’s issue of the journal Nature, and is making the model available as open source through GitHub. . . . → Read More: Generative A.I. Designs Novel Synthetic Proteins

Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients

Cannabis plant

A clinical trial in a small group of participants suggests a cannabinoid drug is safe and well-tolerated, and reduces agitation among patients with Alzheimer’s disease. . . . → Read More: Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients

Start-Up Developing Precision Antibiotics for Resistant Bacteria

Pseudomonas Aeruginosa bacteria

A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria

Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Adeno-associated virus

A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. . . . → Read More: Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Peanut Allergy Toothpaste Shown Safe in Trial

A woman brushing her teeth

Results of a clinical trial show a peanut allergy treatment formulated as a toothpaste can safely deliver immunotherapy to raise recipients’ peanut tolerance. . . . → Read More: Peanut Allergy Toothpaste Shown Safe in Trial

Life Science Incubator Gains $100M in Start-Up Funds

Raven in a tree

A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds

Merger to Form Programmable Nano-Medicines Company

Molecule model in an open hand

A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties. . . . → Read More: Merger to Form Programmable Nano-Medicines Company

Coalition to Boost African Ancestry Genomic Data

Population genetics

An historically Black medical college and pharmaceutical industry group began a program to increase the numbers of people of African descent in genomic databases. . . . → Read More: Coalition to Boost African Ancestry Genomic Data

High-Speed Biologic Injection Device Shown Feasible

Racing motorcycle

A developer of an auto-injection technology says its device can deliver a biologic drug under the skin in a fraction of the time of conventional syringes. . . . → Read More: High-Speed Biologic Injection Device Shown Feasible

Botox Vs Dysport: Similarities And Difference

It is essential for aesthetic practitioners to remain aware of the non-bioequivalency of these formulations and to exercise caution against direct dose conversions. . . . → Read More: Botox Vs Dysport: Similarities And Difference